UNITAID channels its funds through partners active in the fight against HIV/AIDS, malaria and tuberculosis. In assessing partners requests for funds, UNITAID through its Executive Board selects projects that are committed to influencing UNITAID's niches for medicines, diagnostics and related commodities and are expected have a positive impact on the market. All UNITAID funding requests are reviewed by an advisory group of external experts.
Once a project has been approved and the funds committed, the implementing partner and UNITAID enter into negotiations with quality-assured manufacturers to achieve two main goals: ensuring that the needed products are available in a timely manner, and reducing their price through bulk purchasing and pool procurement. Having secured these objectives, the partners purchase the products and supply them to countries through national partners which may include governments, NGOs and procurement agents. UNITAID is in regular contact with partners, and systematically monitors projects progress and results.
In order to refine its process for assessing project proposals, UNITAID set up an Interim Expert Advisory Group in 2008 to screen and evaluate project submissions against UNITAID's strategic objective of achieving health outcomes through market impact. In 2009, the organization hopes to have a permanent Expert Advisory Group made up of external experts in public health, market dynamics, health economics, supply chain management and intellectual property.
UNITAID's grantees include:
- Clinton Health Access Initiative (CHAI)
- Foundation for Innovative New Diagnostics (FIND)
- Medicines for Malaria Venture (MMV)
- TB alliance
- Stop TB Partnership - Global Drug Facility
- The Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria
- Drugs for Neglected Diseases initiative (DNDi)
- Médecins Sans Frontières
- France Expertise Internationale (FEI)
- Malaria Consortium
- World Health Organization.